FINANCIAL TIES AS PART OF INFORMED CONSENT TO POSTMARKETING RESEARCH - ATTITUDES OF AMERICAN DOCTORS AND PATIENTS

被引:23
作者
LAPUMA, J
STOCKING, CB
RHOADES, WD
DARLING, CM
机构
[1] UNIV CHICAGO,CTR CLIN MED ETH,CHICAGO,IL 60637
[2] LUTHERAN GEN HOSP,PARK RIDGE,IL 60068
关键词
D O I
10.1136/bmj.310.6995.1660
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Postmarketing research, often called phase IV trials, is intended to familiarise doctors and patients with newly approved drugs. La Puma and colleagues, in Chicago, studied doctors' and patients' attitudes to whether doctors should receive payment for taking part in such research. We asked for commentaries on their findings from four ethical experts, who put the study in a British context, present the views of patients, and examine some methodological assumptions.
引用
收藏
页码:1660 / 1661
页数:2
相关论文
共 6 条
[1]   PHYSICIAN REWARDS FOR POSTMARKETING SURVEILLANCE (SEEDING STUDIES) IN THE US [J].
LAPUMA, J .
PHARMACOECONOMICS, 1995, 7 (03) :187-190
[2]  
LAPUMA J, 1994, HOSP HLTH SERV ADM, V39, P93
[3]   EVALUATING DRUGS AFTER THEIR APPROVAL FOR CLINICAL USE [J].
RAY, WA ;
GRIFFIN, MR ;
AVORN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27) :2029-2032
[4]   MARKETING ASPECTS OF COMPANY-SPONSORED POSTMARKETING SURVEILLANCE STUDIES [J].
STEPHENS, MDB .
DRUG SAFETY, 1993, 8 (01) :1-8
[5]  
1994, NATIONAL I HLTH GUID, V23, P1
[6]  
1988, BRIT MED J, V296, P399